President & CEO, Inovio Pharmaceuticals

Dr. J. Joseph Kim is leading Inovio Pharmaceuticals in COVID-19 vaccine development. Dr. Kim has led Inovio’s transformation into successful late-stage biotech focused on developing breakthrough DNA medicines that treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases. An immunologist by training, Dr. Kim has a deep understanding of the complexities of medical science’s most extraordinary unsolved challenges. He is committed to improving the lives of patients, and this passion permeates the company.